SCHEMBL26806952

SCHEMBL26806952

CC(=O)c1ccccc1OC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.60
HSD17B10 Q99714 5/20 0.60
ALDH1A1 P00352 4/20 0.60
HPGD P15428 4/20 0.60
ESR1 P03372 1/20 0.60
ITGB3 P05106 1/20 0.60
ITGA2B P08514 1/20 0.60
HMGB1 P09429 1/20 0.60
TSHR P16473 1/20 0.60
GGT1 P19440 1/20 0.60
PTGS1 P23219 1/20 0.60
PTGS2 P35354 1/20 0.60
BLM P54132 1/20 0.60
NAPRT Q6XQN6 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
KMT2A Q03164 3/20 0.57
LMNA P02545 5/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29361191 1.00 KDM4E (0.60) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL11050544 0.85 KDM4E (0.74) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL1004350 0.85 KMT2A (0.59) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL25431708 0.84 KDM4E (0.56) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL766761 0.83 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL26490187 0.82 SLC6A3 (0.72) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL29080260 0.82 KMT2A (0.49) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL28362029 0.82 KMT2A (0.65) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL16865727 0.82 KMT2A (0.56) KDM4EHSD17B10ALDH1A1HPGDESR1
SCHEMBL6152575 0.81 HSD17B10 (0.54) KDM4EHSD17B10ALDH1A1HPGDESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381327-A1 REACTIVE CONJUGATES DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381327-A1 REACTIVE CONJUGATES FCGR3B, FCGR1A, FCGR2A KDM4E 3268/4885HSD17B10 2786/4885ALDH1A1 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.